title: NICE is too generous in approving drugs, analysis says.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D017277:Drug Approval; D006077:Government Agencies; D006801:Humans; D019057:Quality-Adjusted Life Years; D013222:State Medicine; D006113:United Kingdom